Drreddys Laboratories reported INR309M in Interest Expense on Debt for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Ani Pharmaceuticals ANIP:US USD 7.26M 595K
Aurora Cannabis Inc ACB:CN CAD 10.57M 4.2M
Canopy Growth Corp WEED:CN CAD 30.47M 3.57M
Catalent CTLT:US USD 32M 0
Endo International Ordinary Shares ENDP:US USD 74.93M 65M
Lannett LCI:US USD 15.03M 222K
Lonza Group LONN:SW CHF 36M 8M
Novartis NOVN:VX USD 215M 13M
Pacira Pharmaceuticals PCRX:US USD 9.86M 1.02M
Prestige Brands PBH:US USD 16.98M 1.69M
Richter Gedeon RICHT:HB HUF 292M 4.47B
Teva Pharmaceutical TEVA:IT USD 230M 5M